INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 125 filers reported holding INTERSECT ENT INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $463,000 | -4.1% | 16,532 | -6.6% | 0.00% | +50.0% |
| Q4 2021 | $483,000 | -2.6% | 17,696 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $496,000 | +55.5% | 18,225 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $319,000 | -19.4% | 18,658 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $396,000 | -8.5% | 18,956 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $433,000 | +36.6% | 18,905 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $317,000 | +17.8% | 19,447 | -2.2% | 0.00% | +100.0% |
| Q2 2020 | $269,000 | +25.1% | 19,890 | +9.4% | 0.00% | 0.0% |
| Q1 2020 | $215,000 | -55.1% | 18,182 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $479,000 | +45.2% | 19,232 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $330,000 | -25.8% | 19,394 | -0.7% | 0.00% | -50.0% |
| Q2 2019 | $445,000 | -27.5% | 19,530 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $614,000 | +10.6% | 19,091 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $555,000 | -2.8% | 19,709 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $571,000 | -21.0% | 19,859 | +2.9% | 0.00% | -33.3% |
| Q2 2018 | $723,000 | +8.2% | 19,297 | +13.5% | 0.00% | +50.0% |
| Q1 2018 | $668,000 | +15.2% | 16,998 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $580,000 | +7.0% | 17,912 | +2.9% | 0.00% | 0.0% |
| Q3 2017 | $542,000 | +20.4% | 17,415 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $450,000 | +67.3% | 16,112 | +2.6% | 0.00% | +100.0% |
| Q1 2017 | $269,000 | +52.0% | 15,704 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $177,000 | -99.9% | 14,667 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $232,943,000 | +22.7% | 14,706 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $189,864,000 | +19.4% | 14,684 | +75.5% | 0.00% | 0.0% |
| Q1 2016 | $159,000,000 | -15.4% | 8,366 | +0.4% | 0.00% | 0.0% |
| Q4 2015 | $188,000,000 | +96310.3% | 8,334 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $195,000 | -99.9% | 8,349 | +1.1% | 0.00% | 0.0% |
| Q2 2015 | $236,455,000 | +148.3% | 8,259 | +124.0% | 0.00% | – |
| Q1 2015 | $95,235,000 | +39.2% | 3,687 | 0.0% | 0.00% | – |
| Q4 2014 | $68,394,000 | – | 3,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |